Global Herpes Zoster Treatment Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Herpes Zoster Treatment market size will reach US$ million by 2031.
Herpes Zoster, also known as zoster or shingles, is a viral disease characterized by a painful skin rash with blisters in a localized area. Typically the rash occurs in a single, wide stripe either on the left or right side of the body or face. Two to four days before the rash occurs there may be tingling or local pain in the area. Otherwise there are typically few symptoms though some may have fever, headache, or feel tired. The rash usually heals within two to four weeks; however, some people develop ongoing nerve pain which can last for months or years, a condition called postherpetic neuralgia (PHN). In those with poor immune function the rash may occur widely. If the rash involves the eye, vision loss may occur.
United States market for Herpes Zoster Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Herpes Zoster Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Herpes Zoster Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Herpes Zoster Treatment players cover Roche, Novartis, Merck, GlaxoSmithKline, Abbott Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Herpes Zoster Treatment Industry Forecast” looks at past sales and reviews total world Herpes Zoster Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Herpes Zoster Treatment sales for 2025 through 2031. With Herpes Zoster Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Herpes Zoster Treatment industry.
This Insight Report provides a comprehensive analysis of the global Herpes Zoster Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Herpes Zoster Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Herpes Zoster Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Herpes Zoster Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Herpes Zoster Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Herpes Zoster Treatment market by product type, application, key players and key regions and countries.
Segmentation by Type:
Oral
Topical
Others
Segmentation by Application:
Hospitals
Clinics
Home Care Settings
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche
Novartis
Merck
GlaxoSmithKline
Abbott Laboratories
Astellas Pharma
Bausch Health Companies
Teva Pharmaceutical
Foamix Pharmaceuticals
Please note: The report will take approximately 2 business days to prepare and deliver.
Herpes Zoster, also known as zoster or shingles, is a viral disease characterized by a painful skin rash with blisters in a localized area. Typically the rash occurs in a single, wide stripe either on the left or right side of the body or face. Two to four days before the rash occurs there may be tingling or local pain in the area. Otherwise there are typically few symptoms though some may have fever, headache, or feel tired. The rash usually heals within two to four weeks; however, some people develop ongoing nerve pain which can last for months or years, a condition called postherpetic neuralgia (PHN). In those with poor immune function the rash may occur widely. If the rash involves the eye, vision loss may occur.
United States market for Herpes Zoster Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Herpes Zoster Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Herpes Zoster Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Herpes Zoster Treatment players cover Roche, Novartis, Merck, GlaxoSmithKline, Abbott Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Herpes Zoster Treatment Industry Forecast” looks at past sales and reviews total world Herpes Zoster Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Herpes Zoster Treatment sales for 2025 through 2031. With Herpes Zoster Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Herpes Zoster Treatment industry.
This Insight Report provides a comprehensive analysis of the global Herpes Zoster Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Herpes Zoster Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Herpes Zoster Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Herpes Zoster Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Herpes Zoster Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Herpes Zoster Treatment market by product type, application, key players and key regions and countries.
Segmentation by Type:
Oral
Topical
Others
Segmentation by Application:
Hospitals
Clinics
Home Care Settings
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche
Novartis
Merck
GlaxoSmithKline
Abbott Laboratories
Astellas Pharma
Bausch Health Companies
Teva Pharmaceutical
Foamix Pharmaceuticals
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
82 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Herpes Zoster Treatment Market Size by Player
- 4 Herpes Zoster Treatment by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Herpes Zoster Treatment Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
